Stephen Alzuphar
Papers
1
Total Citations
32
H-Index
1
About
Stephen Alzuphar is a leading surgical oncologist whose research focuses on refining treatment paradigms for oropharyngeal cancer (OPC), particularly through the use of transoral robotic surgery (TORS). His major contribution lies in demonstrating that, for carefully selected patients—those without radiographic extracapsular extension (ECS) and with surgically revised margins—adjuvant therapy can be safely minimized or even omitted. This work, published in a prospective cohort study (32 citations), challenges traditional aggressive post-surgical protocols, aiming to reduce treatment-related morbidity without compromising oncologic outcomes. Alzuphar’s research bridges surgical precision and patient-centered care, offering a pathway to de-escalation in head and neck oncology. His findings have influenced clinical decision-making, encouraging a shift toward more individualized, less toxic treatment strategies. By integrating radiographic and pathological criteria, Alzuphar has provided a reproducible framework for selecting candidates who can avoid unnecessary radiation or chemotherapy. His work is particularly impactful for students and clinicians seeking to understand how modern robotic techniques can be leveraged to improve quality of life while maintaining survival rates in OPC patients.
Research Focus
Key Achievements
Top Papers
- 1